trial

tDCS for Cognitive Impairment Associated With Recent-onset Schizophrenia

NCTId NCT05440955
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Not Yet Recruiting
Enrollment 60 (estimated)
Sponsored by University Hospital, Grenoble
Primary completion 2026-06-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Not Yet Recruiting
Enrollment
60 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2023-06-01
Primary completion
2026-06-01
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
left fronto-temporal transcranial Direct Current Stimulation (tDCS)

Sponsors

University Hospital, GrenobleLead Sponsor
Direction Générale de l'Offre de SoinsCollaborator

Investigators

1
Clément DondéPrincipal Investigator

Sites

4 total
La Tronche, FranceSaint-Égrève, FranceBron, FranceSaint-Etienne, France

Facts & assertions

4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2026-06-01
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
left fronto-temporal transcranial Direct Current Stimulation (tDCS)
drug
lead_sponsor
University Hospital, Grenoble
company
collaborator
Direction Générale de l'Offre de Soins
company
indication
Cognitive Dysfunction
indication
Schizophrenia
indication
Psychotic Disorders
indication
investigator
Clément Dondé
person